Declan Doogan
Declan Doogan has made 1 open-market purchase worth $102k since Sep 18, 2026, in 1 company. The latest: $102k of TENX, filed Sep 18, 2026, scored 38 out of 100.
Director, TENAX THERAPEUTICS, INC.
Follow Declan Doogan, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Sep 18 Form 4 (opens sec.gov) |
TENXTENAX THERAPEUTICS, INC. · DirectorDirector · Near 52-week low · Penny stock: hard to trade | +999% stake | 38 | $102k 53,000 at $1.92 |
−4.7% | −20.0% |
Track record (hypothetical): a week after the filing, these buys averaged −4.7% (0% up, 1 measured); a month after, −20.0% (0% up, 1 measured).
Questions
What stock has Declan Doogan bought?
TENX (TENAX THERAPEUTICS, INC.), all on the open market and reported on SEC Form 4.
When did Declan Doogan last buy?
Sep 18, 2026: 53,000 shares of TENX at $1.92, $102k in all (Form 4 (opens sec.gov)).
Has Declan Doogan filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Declan Doogan a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Sep 18, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer